These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8182939)

  • 41. Analysis of gangliosides from carp intestinal mucosa.
    Irie T; Watarai S; Kushi Y; Kasama T; Kodama H
    Fish Shellfish Immunol; 2004 Feb; 16(2):117-25. PubMed ID: 15123316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gangliosides of human acute leukemia cells.
    Westrick MA; Lee WM; Goff B; Macher BA
    Biochim Biophys Acta; 1983 Jan; 750(1):141-8. PubMed ID: 6572071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New method for quantitative analysis of GD2 ganglioside in plasma of neuroblastoma patients.
    Czaplicki D; Horwacik I; Kowalczyk A; Wieczorek A; Bolek-Marzec K; Balwierz W; Kozik A; Rokita H
    Acta Biochim Pol; 2009; 56(3):423-31. PubMed ID: 19724779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.
    Ravindranath MH; Morton DL; Irie RF
    Cancer Res; 1989 Jul; 49(14):3891-7. PubMed ID: 2472199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of an Ig VH idiotope that results in specific homophilic binding and increased avidity for antigen.
    Yan X; Evans SV; Kaminki MJ; Gillies SD; Reisfeld RA; Houghton AN; Chapman PB
    J Immunol; 1996 Aug; 157(4):1582-8. PubMed ID: 8759742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ganglioside expression in lung cancer cell lines.
    Fuentes R; Allman R; Mason MD
    Lung Cancer; 1997 Aug; 18(1):21-33. PubMed ID: 9268945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanoma.
    Bajorin DF; Chapman PB; Wong GY; Cody BV; Cordon-Cardo C; Dantes L; Templeton MA; Scheinberg D; Oettgen HF; Houghton AN
    Melanoma Res; 1992 Dec; 2(5-6):355-62. PubMed ID: 1292783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted delivery of immunotoxin by antibody to ganglioside GD3: a novel drug delivery route for tumor cells.
    Torres Demichelis V; Vilcaes AA; Iglesias-Bartolomé R; Ruggiero FM; Daniotti JL
    PLoS One; 2013; 8(1):e55304. PubMed ID: 23383146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue distribution of GD3 ganglioside detected by mouse monoclonal antibody R24.
    Urmacher C; Cordon-Cardo C; Houghton AN
    Am J Dermatopathol; 1989 Dec; 11(6):577-81. PubMed ID: 2604027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of a tumour-associated ganglioside in plasma of patients with neuroblastoma.
    Ladisch S; Wu ZL
    Lancet; 1985 Jan; 1(8421):136-8. PubMed ID: 2857215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic value of ganglioside patterns in plasma of human diseases.
    Ayabe M; Shichijo S; Yokoyama MM
    J Clin Lab Anal; 1989; 3(5):301-6. PubMed ID: 2809880
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distribution of the ganglioside GD3 in the human nervous system detected by R24 mouse monoclonal antibody.
    Graus F; Cordon-Cardo C; Houghton AN; Melamed MR; Old LJ
    Brain Res; 1984 Dec; 324(1):190-4. PubMed ID: 6394100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolation and characterization of ganglioside 9-O-acetyl-GD3 from bovine buttermilk.
    Bonafede DM; Macala LJ; Constantine-Paton M; Yu RK
    Lipids; 1989 Aug; 24(8):680-4. PubMed ID: 2685488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A reappraisal of ganglioside GD3 expression in the CNS.
    Goldman JE; Reynolds R
    Glia; 1996 Apr; 16(4):291-5. PubMed ID: 8721669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Levels of disialogangliosides in sera of melanoma patients monitored by sensitive thin-layer chromatography and immunostaining.
    Sela BA; Iliopoulos D; Guerry D; Herlyn D; Koprowski H
    J Natl Cancer Inst; 1989 Oct; 81(19):1489-92. PubMed ID: 2778837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fetal calf serum gangliosides: quantitation and immunodetection of minor ones with R24 and A2B5 monoclonal antibodies.
    Harpin ML; Younes-Chennoufi AB; Boutry JM; Goujet-Zalc C; Hauw JJ; Yavin E; Baumann N
    In Vitro Cell Dev Biol; 1990 Mar; 26(3 Pt 1):217-9. PubMed ID: 2180899
    [No Abstract]   [Full Text] [Related]  

  • 57. Changes in plasma gangliosides in relation to tumor growth and their tumor-enhancing effect.
    Saha S; Chattopadhyay U
    Int J Cancer; 1988 Mar; 41(3):432-5. PubMed ID: 3346109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new procedure for determining ganglioside GD3 a potential glial cell activation marker in cerebrospinal fluid.
    Lekman A; Fredman P
    Neurochem Int; 1998 Aug; 33(2):103-8. PubMed ID: 9761454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolation and purification of gangliosides from plasma.
    Ladisch S; Gillard B
    Methods Enzymol; 1987; 138():300-6. PubMed ID: 3600328
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of plasma gangliosides on the growth of Ehrlich ascites tumor.
    Saha S; Ghosh A
    Int J Cancer; 1990 Oct; 46(4):691-4. PubMed ID: 2210885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.